{{Rsnum
|rsid=11661856
|Chromosome=18
|position=77941567
|Orientation=plus
|GMAF=0.02388
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 1.8 | 9.0 | 89.2
| HCB | 0.0 | 1.5 | 98.5
| JPT | 0.0 | 0.9 | 99.1
| YRI | 0.0 | 2.8 | 97.2
| ASW | 0.0 | 3.5 | 96.5
| CHB | 0.0 | 1.5 | 98.5
| CHD | 0.0 | 0.9 | 99.1
| GIH | 0.0 | 1.0 | 99.0
| LWK | 0.0 | 3.7 | 96.3
| MEX | 0.0 | 6.9 | 93.1
| MKK | 0.0 | 0.7 | 99.3
| TSI | 0.0 | 12.9 | 87.1
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22228203
|Trait=None
|Title=A genome-wide association study of inflammatory biomarker changes in response to fenofibrate treatment in the Genetics of Lipid Lowering Drug and Diet Network.
|RiskAllele=
|Pval=0.000001
|OR=None
|ORtxt=None
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}